Registers Resale of 3.02M Shares from Warrants, Enabling $19.08M Capital Raise Amid Extreme Dilution
XXII sits 20% above its 52-week low of $5.414.
Summary
22nd Century Group registers 3.02 million shares for resale by warrant holders, potentially raising $19.08 million for the company but creating massive dilution and selling pressure for existing shareholders.
Key Events · Financing and Capital Events · XXII
-
Resale Registration
Registers 3,019,586 shares of common stock for resale by selling stockholders. These shares are issuable upon the exercise of warrants issued in a private placement on June 9, 2026.
-
Potential Capital Infusion
The company could receive up to $19.08 million if all warrants are exercised for cash, providing a crucial source of funds given its "going concern" status.
-
Extreme Dilution Potential
The 3.02 million shares represent a potential dilution of approximately 585% relative to the 516,328 outstanding shares (post-split), creating substantial selling pressure.
-
Anti-Dilution Provisions
The warrants and Series B Convertible Preferred Stock include anti-dilution price protection, which could further reduce exercise/conversion prices if future offerings occur at lower prices.
Analysis · XXII · Manufacturing
This S-3 filing registers 3.02 million shares of common stock for resale by selling stockholders, which are issuable upon the exercise of warrants issued in a private placement on June 9, 2026. While the company could receive up to $19.08 million if all warrants are exercised for cash, providing a critical capital infusion given its "going concern" doubts, the potential for these shares to enter the market represents an extreme dilution of approximately 585% relative to current outstanding shares and a significant overhang for existing shareholders. This follows a series of dilutive capital raises and comes after a 1-for-20 reverse stock split.
At the time of this filing, XXII was trading at $6.51 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $28.2M. The 52-week trading range was $5.41 to $4,899.69. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.